-
Rituximab More Effective Than Gilenya, Tecfidera in MS, Study Finds
A study has found that the effectiveness of rituximab appeared to be comparable to that of Tysabri (natalizumab), but with fewer treatment discontinuations. Click here to read more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.